Sigyn Therapeutics, Inc. SEC filings SIGY

Sigyn Therapeutics, Inc. has 175 filings in SEC EDGAR's recent list, going back to May 27, 2015. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Feb 20, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14C Information statement Sep 21, 2020 Sep 18, 2020
PRE 14C Filing Sep 9, 2020 Sep 9, 2020
DEF 14C Information statement Mar 10, 2020 Feb 24, 2020
PRE 14C Filing Feb 25, 2020 Feb 24, 2020
DEF 14C Information statement Oct 2, 2019 Oct 2, 2019
PRE 14C Preliminary information statement Sep 17, 2019 Sep 17, 2019
DEF 14A Proxy statement Feb 23, 2017 Feb 22, 2017
PRE 14A Preliminary proxy statement Feb 8, 2017 Feb 8, 2017

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SIGY (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1642159
Former names
Reign Resources Corp (until Oct 23, 2020); Reign Sapphire Corp (until May 12, 2020)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.